Contacto

Human Complement C4 (C4) CLIA Kit

618,75 (96 tests)

Human Complement C4 (C4) CLIA Kit is a CLIA kit against Complement C4 (C4).

Proveedor

Abbexa

Reference

abx195280

Tested Applications

CLIA

Reactivity

Human

Status

RUO

Si quieres saber los precios con descuentos por volumen o bien más características del producto, contáctanos!

Características de producto

tested_applications
CLIA
reactivity
Human
category
CLIA Kits
Immunogen / Target
Complement C4 (C4)
size_1
96 tests
storage
Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual.
test_range
93.75 pg/ml - 6000 pg/ml
sensitivity
56.25 pg/ml
detection_method
Chemiluminescent
assay_type
Sandwich
assay_data
Quantitative
availability
Shipped within 5-12 working days.
dry_ice
No
note
This product is for research use only.

The range and sensitivity is subject to change. Please contact us for the latest product information. For accurate results, sample concentrations must be diluted to mid-range of the kit. If you require a specific range, please contact us in advance or write your request in your order comments.

Please note that our ELISA and CLIA kits are optimised for detection of native samples, rather than recombinant proteins. We are unable to guarantee detection of recombinant proteins, as they may have different sequences or tertiary structures to the native protein.
background
Complement component 4 (C4), in humans, is a protein involved in the intricate complement system, originating from the human leukocyte antigen (HLA) system. It serves a number of critical functions in immunity, tolerance, and autoimmunity with the other numerous components. Furthermore, it is a crucial factor in connecting the recognition pathways of the overall system instigated by antibody-antigen (Ab-Ag) complexes to the other effector proteins of the innate immune response. For example, the severity of a dysfunctional complement system can lead to fatal diseases and infections. Complex variations of it can also lead to schizophrenia. Target